Mr. Javid Ahmed Malik "International young scientist Award"



At the "6th International science congress" which is orgainiged by the  "International science community Association" (registered under Ministry of corporate Affairs ,govt. of India) at Hutatma Rajguru Mahavidyalaya; Pune, Maharashtrsa, India; Mr. Javid Ahmed Malik  has won the "International young scientist Award". 

                                                                       Mr.Javed Ahmed Malik is a research scholar in the department of Zoology from GGU. who has recently been awarded for his outstanding invention on his research and scientific work for characterigation of Tephrosia Purpurea Linn so as to unravel the hepatoprotective potential against anti-tubercular drugs induced hepatotoxicity that was presented in Pharmaceutical Science section. The outcome of the scientific investigatons will be helpful in establishing an excellent  hepato-protective drug against Tuberculosis. His study was aimed to characterize Tephrosia purpurea  extract for its hepatophrotective potential against anti-tubercular drugs. For this,the plant was collected and processed to obtain the extract. Then, this extract along with the anti-tubercular drugs were given to experimental white rats for about two months. On observation, the researcher found the hepatoprotective effects of the plant extract. This experimentation was conducted at Toxicology and pharmacology Laboratry of Department of Zoology, under the supervision of Dr. Monika Bhadauria. The research program was financiaaly supported by the UGC-MRP and UGC-BSR.

Read More

Category : People who Achieved    11/04/2017


Interview Gita Mishra



I am Gita Mishra, a research scholar at the department of Zoology, GGV. I am working under the supervision of Dr. Monika Bhadauria, associate professor at the Toxicology and pharmacology laboratory. I have been awarded with the Chhattisgarh young scientist award along with a cash prize of 21000 rupees and also an opportunity to work at any research institute to enhance my research.

My area of intret is to explore herbal remedies and to use them against drug induced side effects. Chhattisgarh is a home to a great variety of ethno medical plant species. Herbal medicines use different photochemical for the preventions and treatment of diseases which varies from traditional medicines of ancient times to present day standardized herbal drugs.

First line anti-tuberculosis drugs are used as an effective therapy against tuberculosis. Inspire of the availability of anti-tuberculosis drugs, around 1.4 million people died to tuberculosis in 2015. Major hurdle in tuberculosis eradication is noncompliance of the patients towards the drug. Due to the highly toxic effect of the drug, patients are unable to continue with the therapy for more than 6 months. Multi drug resistance hampers the random use of clinical medicines. The major challenge is to deal with the side effects of the drugs along with the disease itself. Herbal medicines are cheaper because of their easy availability.  Herbal medicines are already accepted as an alternative. However clinical medicines use many plant derived metabolites in pharmaceutical drugs.

Drug included liver Injury (DILI) is a major health issue in India. India, Indonesia, china, Nigeria, Pakistan and South Africa accounted for 60% of the new cases. According to the Global tuberculosis report 2016, India accounts for more than a quarter of the world’s tuberculosis cases and deaths. Pathogenesis of ATD’s related hepatoxicity is not clearly known but oxidative stress is one of the mechanism which plays a central role in the pathogenesis of ATD induced hepatitis. Hemidesumus indices (Anantmool) is available in Chhattisgarh and India. My research work is an attempt to evaluate therapeutic potential of Hemidesmus indices against the first line anti –tuberculosis drug induced hepato-renal injury. The outcome if the study would be helpful in establishing plant based therapy and ATD included hepatic and renal diseases which would be beneficial for the patients to continue with their tuberculosis treatment.  

Read More

Category : People who Achieved    06/04/2017